期刊文献+

碳青霉烯类抗生素的开发与临床应用 被引量:19

Exploitation and clinical applicarion of carbapenems antibiotics
下载PDF
导出
摘要 目的:促进对碳青霉烯类抗生素在临床的合理应用。方法:分3类对碳青霉烯类抗生素的开发史、药理与药效、临床评价、药物相互作用及用法等进行阐述,结合临床应用情况,分析比较了5个品种之间的不同特点。结果:本组抗生素具有抗茵谱广、抗茵活性强和对β-内酰胺酶高度稳定的特性,经临床验证其抗感染疗效确切。结论:对混合性严重感染及时合理地选择碳青霉烯类抗生素是十分有效的。
出处 《上海医药》 CAS 2004年第3期109-111,共3页 Shanghai Medical & Pharmaceutical Journal
  • 相关文献

参考文献15

二级参考文献47

  • 1潘启超.抗生素后效作用及其在感染治疗中的意义[J].中国临床药理学杂志,1993,9(4):220-225. 被引量:24
  • 2王晓陶,雷振之,鞠长德.环丙沙星、头孢他啶、头孢米诺、氨曲南、亚胺培南/西司他丁和奈替米星的体外抗生素后效应[J].中国抗生素杂志,1996,21(3):220-224. 被引量:6
  • 3[1]Livermore DM, Carter MW, Bagel S, et al. In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia[J]. Antimicrob Agents Chemother, 2001,45(6): 1860- 1867.
  • 4[2]Odenholt 1, Lowdin E, Cars O. In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against grarn-positive and gram-negative bacteria [J]. Antimicrob Agents Chemother, 1998, 42(9): 2365 - 2370.
  • 5[3]Hoellman DB, Kelly LM, Credito K, et al. In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds[J]. Antimicrob Agents Chemother, 2002, 46 ( 1 ): 220-224.
  • 6[4]Gill CJ, Jackson JJ, Gerckens LS, et al. In vivo activity and phar macokinetic of a novel long-acting carbapenem antibiotic, MK-826(L-749,345) [J]. Antimicrob Agents Chemother, 1998, 42 ( 8 ):1996-2001.
  • 7[5]Sundelof JG, Hajdu R, Gill CJ, et al. Pharmacokinetics of L-749345, a long-acting carbapenem antibiotic, in primates[J]. Antimicrob Agents Chemother, 1997, 41(8): 1743 - 1748.
  • 8[6]Ortiz-Ruiz G, Caballero-Lopez J, Friedland IR, et al. A study eval uating the efficacy, safety, and tolerability of ertapenem versus cef triaxone for the treatment of community-acquired pneumonia in adults[J]. Clin Infect Dis, 2002, 34(8): 1076 - 1083.
  • 9[7]Tomera KM, Burdmann EA, Reyna OG, et al. Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study [J]. Antimicrob Agents Chemother, 2002, 46 (9): 2895 - 2900.
  • 10[8]Jimenez-Cruz F, Jasovich A, Cajigas J, et al. A prospective, multi center, randomized, double-blind study comparing ertapenem and ceftriaxone followed by appropriate oral therapy for complicated urinary tract infections in adults[J]. Urology, 2002, 60( 1 ): 16 -22.

共引文献108

同被引文献174

引证文献19

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部